Stock Track | BridgeBio Pharma Soars 5.40% in Pre-Market on Multiple Analyst Price Target Hikes

Stock Track

Feb 25

BridgeBio Pharma, Inc. (BBIO) saw its stock price surge 5.40% during pre-market trading on Wednesday, following a series of positive analyst actions.

The pre-market rally was fueled by several investment firms raising their price targets for the biopharmaceutical company. Barclays maintained its Buy rating with a price target of $157.00, while Leerink Partners increased its target to $98 from $95. Morgan Stanley lifted its price target to $98 from $96 and reaffirmed its Overweight rating, and Truist Securities raised its target to $95 from $86.

These upward revisions from multiple analysts indicate growing confidence in BridgeBio Pharma's prospects, likely driving increased investor interest and buying activity ahead of the market open.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1106645101"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1106645101\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1106645101?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 21:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106645101","market":"sg","top_or_hot":-1,"title":"Stock Track | BridgeBio Pharma Soars 5.40% in Pre-Market on Multiple Analyst Price Target Hikes","media":"Stock Track","content":"<p>BridgeBio Pharma, Inc. (BBIO) saw its stock price surge 5.40% during pre-market trading on Wednesday, following a series of positive analyst actions.</p><p>The pre-market rally was fueled by several investment firms raising their price targets for the biopharmaceutical company. Barclays maintained its Buy rating with a price target of $157.00, while Leerink Partners increased its target to $98 from $95. Morgan Stanley lifted its price target to $98 from $96 and reaffirmed its Overweight rating, and Truist Securities raised its target to $95 from $86.</p><p>These upward revisions from multiple analysts indicate growing confidence in BridgeBio Pharma's prospects, likely driving increased investor interest and buying activity ahead of the market open.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BridgeBio Pharma Soars 5.40% in Pre-Market on Multiple Analyst Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BridgeBio Pharma Soars 5.40% in Pre-Market on Multiple Analyst Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-25 21:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BridgeBio Pharma, Inc. (BBIO) saw its stock price surge 5.40% during pre-market trading on Wednesday, following a series of positive analyst actions.</p><p>The pre-market rally was fueled by several investment firms raising their price targets for the biopharmaceutical company. Barclays maintained its Buy rating with a price target of $157.00, while Leerink Partners increased its target to $98 from $95. Morgan Stanley lifted its price target to $98 from $96 and reaffirmed its Overweight rating, and Truist Securities raised its target to $95 from $86.</p><p>These upward revisions from multiple analysts indicate growing confidence in BridgeBio Pharma's prospects, likely driving increased investor interest and buying activity ahead of the market open.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BBIO","symbol_name":"BridgeBio Pharma, Inc.","start_time":0,"source_url":"","article_id":"1106645101","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106645101","pubTimestamp":1772024883,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BridgeBio Pharma, Inc. (BBIO) saw its stock price surge 5.40% during pre-market trading on Wednesday, following a series of positive analyst actions.The pre-market rally was fueled by several...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BBIO":"BridgeBio Pharma, Inc."},"translate_title":"个股追踪|多位分析师上调目标价，BridgeBio Pharma盘前大涨5.40%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BBIO":1},"content_text":"BridgeBio Pharma, Inc. (BBIO) saw its stock price surge 5.40% during pre-market trading on Wednesday, following a series of positive analyst actions.The pre-market rally was fueled by several investment firms raising their price targets for the biopharmaceutical company. Barclays maintained its Buy rating with a price target of $157.00, while Leerink Partners increased its target to $98 from $95. Morgan Stanley lifted its price target to $98 from $96 and reaffirmed its Overweight rating, and Truist Securities raised its target to $95 from $86.These upward revisions from multiple analysts indicate growing confidence in BridgeBio Pharma's prospects, likely driving increased investor interest and buying activity ahead of the market open.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}